Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical and Pharmacokinetic Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors

NCT00551512 is registered in ClinicalTrials.gov with CanBas Co. Ltd. as lead sponsor.

NCT NCT00551512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical and Pharmacokinetic Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors
Lead sponsor
CanBas Co. Ltd.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2006
Completion date
May 31, 2009
Enrollment
48 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, solid tumors